No posts to display
Top News
AI-Powered Antibody Drug Development: Samsung Biologics and Protina’s Game-Changing License Agreement
Samsung Bioepis and Protina sign a licensing agreement to develop AI-designed antibody drugs, aiming for candidates by 2027.
- Our Sponsors Ad -